Last update:

Ophthalmology news

Low dose atropine eye drops safe and effective for short-sightedness in children, clinical trial suggests

Low-concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ.

Researchers identify which eye infections pose greatest threat to vision

Eye surgery today is safer than ever, yet ophthalmologists must remain watchful for a rare but serious complication that can threaten sight within days: a bacterial eye infection called endophthalmitis. Now, clinician-scientists ...

Lab-grown aging eye model reveals early AMD markers in weeks

The rods and cones in your eyes are responsible for helping you see, but what is responsible for helping them? Retinal pigment epithelium cells are their caretakers, but environmental, genetic and aging factors can strain ...

New genetic map of the human eye reveals clues to vision loss

An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help explain why millions of ...

Eye drop formulation can treat dry eye disease

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease. The team reports in Investigative Ophthalmology ...

Project expands access to care for children with amblyopia

A group of pediatric eye disease researchers has launched an open-access tool designed to help manage pediatric cases of amblyopia, a condition in which the brain fails to properly develop normal vision in one or both eyes ...

Low-dose eye drops can manage adult myopia for 24 hours

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor ...

Seeing keratoconus earlier with light polarization and AI

Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the cornea can still appear normal on routine exams. Yet this is when accurate ...

Device could pave way for human eye transplants

It seemed like a simple idea. Design a device that will make it possible for a human eye to remain alive and functional outside of the body. At least for a few hours. And then a few days.

Indicators of neuropathic ocular pain identified after LASIK

In a study published in the August issue of the American Journal of Ophthalmology, diagnostic indicators are identified for confirming chronic neuropathic ocular pain (NOP) for patients experiencing chronic dry eye (DE) after ...

Eye scan can reveal risk of having a heart attack or stroke

A simple digital photograph of the back of the eye can predict a major cardiovascular event—such as a heart attack or stroke—set to happen in the next decade with 70% accuracy, according to research supported by the British ...

Cancer drug shows promise as treatment for blindness

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness ...

NRTI use linked to risk for primary open-angle glaucoma

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.